An Open-Label Non-Randomized, Multi-Center Phase-2 Study of Convection-Enhanced Delivery (CED) of MDNA55 in Adults with Glioblastoma at First Recurrence or Progression
Clinical Trial Grant
Administered By
Duke Cancer Institute
Awarded By
Medicenna Therapeutics, Inc.
Start Date
February 1, 2017
End Date
March 22, 2022
Administered By
Duke Cancer Institute
Awarded By
Medicenna Therapeutics, Inc.
Start Date
February 1, 2017
End Date
March 22, 2022